000 | 01850 a2200553 4500 | ||
---|---|---|---|
005 | 20250513125552.0 | ||
264 | 0 | _c19971022 | |
008 | 199710s 0 0 eng d | ||
022 | _a0012-3692 | ||
024 | 7 |
_a10.1378/chest.112.3.582 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEllman, M S | |
245 | 0 | 0 |
_aA new index of prognostic severity for chronic asthma. _h[electronic resource] |
260 |
_bChest _cSep 1997 |
||
300 |
_a582-90 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
650 | 0 | 4 |
_aAdrenergic beta-Agonists _xadministration & dosage |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aAirway Obstruction _xphysiopathology |
650 | 0 | 4 |
_aAsthma _xdiagnosis |
650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 | _aCircadian Rhythm |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aForced Expiratory Volume _xdrug effects |
650 | 0 | 4 | _aForecasting |
650 | 0 | 4 | _aHospitalization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNasal Polyps _xphysiopathology |
650 | 0 | 4 |
_aPeak Expiratory Flow Rate _xdrug effects |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aViscoli, C M | |
700 | 1 | _aSears, M R | |
700 | 1 | _aTaylor, D R | |
700 | 1 | _aBeckett, W S | |
700 | 1 | _aHorwitz, R I | |
773 | 0 |
_tChest _gvol. 112 _gno. 3 _gp. 582-90 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1378/chest.112.3.582 _zAvailable from publisher's website |
999 |
_c9293169 _d9293169 |